The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

CRDL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.57%

Insider Buying (Last 12 Months): C$268,668.69

Insider Selling (Last 12 Months): C$0.00

Cardiol Therapeutics Insider Trading History Chart

Cardiol Therapeutics Share Price & Price History

C^$1.81

▲ +0.01 (0.56%)

As of 12/24/2024 02:21 PM ET

Days: 30 | 90 | 365

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Cardiol Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/19/2024	Andrew Warwick Hamer	Senior Officer	Buy	18,900	C$1.88	C$35,606.69
12/17/2024	Bernard Lim	Senior Officer	Buy	10,000	C$1.95	C$19,500.00
12/16/2024	David Elsley	Director	Buy	40,000	C$1.88	C$75,072.00
6/24/2024	David Elsley	Director	Buy	50,000	C$2.77	C$138,490.00
12/28/2022	Guillermo Torre	Senior Officer	Buy	18,245	C$0.52	C$9,441.79

liberals FOOLED by Elon’s shocking surprise

From StocksToTrade | Ad

Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH…

Click here to discover the real reason Elon Musk became buddy-buddy with Trump.

SEC Filings (Institutional Ownership Changes) for Cardiol Therapeutics (TSE:CRDL)

11.41% of Cardiol Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Today's Range

Now: C$1.81

C$1.79

C$1.82

50 Day Range

MA: C$2.32

C$1.80

C$2.90

52 Week Range

Now: C$1.81

C$1.09

C$4.26

Volume

10,756 shs

Average Volume

134,137 shs

Market Capitalization

C$126.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.7

Who are the company insiders with the largest holdings of Cardiol Therapeutics?: Cardiol Therapeutics' top insider investors include:
Andrew Warwick Hamer (Senior Officer)
Bernard Lim (Senior Officer)
David Elsley (Director)
Guillermo Torre (Senior Officer)
Learn More about top insider investors at Cardiol Therapeutics.

Vladimir Lenin was right…